Edwards Lifesciences reported $886.2M in Current Liabilities for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Abiomed ABMD:US $ 128.97M 8.57M
Atricure ATRC:US $ 58.46M 9.33M
Baxter International BAX:US $ 3344M 157M
Becton, Dickinson and BDX:US $ 5376M 1645M
Cardiovascular Systems CSII:US $ 50.45M 2.36M
Cooper Companies COO:US $ 992.7M 31.4M
Cryolife CRY:US $ 58.94M 0.93M
Dexcom DXCM:US $ 600.7M 3.4M
Edwards Lifesciences EW:US $ 886.2M 87.2M
Globus Medical GMED:US $ 123.68M 2.88M
Hill Rom HRC:US $ 945.7M 152.6M
Hologic HOLX:US $ 1464.6M 428.2M
Icu Medical ICUI:US $ 179.86M 15.63M
Inogen INGN:US $ 55.47M 1.24M
Insulet PODD:US $ 185.5M 22.3M
Intuitive Surgical ISRG:US $ 1004.6M 100M
Masimo MASI:US $ 220.03M 23.16M
Medtronic MDT:US $ 8509M 4025M
Merit Medical Systems MMSI:US $ 210.6M 2.93M
Nuvasive NUVA:US $ 193.73M 31.14M
Stryker SYK:US $ 4252M 299M
Tandem Diabetes Care TNDM:US $ 103.41M 0.44M
Teleflex TFX:US $ 526.85M 18.8M